AÎ² modulation of Akt phosphorylation in a transgenic mouse model of AD : the potential role of nicotinic and NMDA receptors

AÎ² modulation of Akt phosphorylation in a transgenic mouse model of AD : the potential role of nicotinic and NMDA receptors

Bibliographic Details
Main Author:	Abbott, Jonathan James
Published:	King's College London (University of London) 2006
Subjects:	616.83104227
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.428583

Similar Items

Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems.
by: Soheil Keihan Falsafi, et al.
Published: (2012-01-01)

Peripheral NMDA receptors in inflammatory and visceral pain
by: Sladek, Meik
Published: (2007)

The role of the striatal NMDA receptor complex in the mediation of Parkinsonism
by: Carroll, Camille Buchholz
Published: (1994)

Nicotinic modulation of cellular and molecular processes : impact of chronic nicotine and its withdrawal
by: Barik, Jacques
Published: (2006)

Determining the role of NMDA receptors and ATP receptors in the pathological damage following stroke
by: Trotman, Melissa Elizabeth
Published: (2015)

Differential Modulation of GABAA and NMDA Receptors by an α7-nicotinic Acetylcholine Receptor Agonist in Chronic Glaucoma
by: Xujiao Zhou, et al.
Published: (2017-12-01)

Investigating the role of glutamate and the NMDA receptor in schizophrenia using FMRI
by: Lees, Jane
Published: (2007)

Phosphorylation of the cardiac ryanodine receptor
by: Carter, Simon Mark
Published: (2006)

Studies of the role of GABA A and NMDA receptors : manipulation in anxiety and cognition
by: Papadopoulos, Andreas
Published: (2011)

Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation
by: Ruth Luthi-Carter, et al.
Published: (2003-12-01)

Analysis of transgenic mouse models of Huntington's disease
by: Deschepper, Mia
Published: (2008)

Immunoregulation in the NOD mouse and NOD transgenic mice
by: Thomas, Thomas David Colin
Published: (2007)

Characterisation of transgenic mouse models of Alzheimer's disease
by: Graham, Lindsay
Published: (2011)

The expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine stimulation
by: Ho-Tai Wu, et al.
Published: (2005)

Neuronal nicotinic receptors as targets for enhancing cognition in schizophrenia
by: Rushforth, Samantha Leigh
Published: (2013)

Controls on T-cell receptor phosphorylation and triggering
by: Fernandes, Ricardo A.
Published: (2011)

Characterisation of nicotine receptors on immune cell lines
by: Summers, Andrea Eva
Published: (2003)

Long-term depression of NMDA receptor-mediated transmission in the CA1 region of the hippocampus
by: Farrow, Paul Andrew
Published: (2010)

Upregulation of neuronal α7 nicotinic acetylcholine receptors and preconditioning
by: Van Rensburg, Ruan
Published: (2007)

Investigation of the mechanisms of estrogen receptor activation by phosphorylation
by: Halliday, Amy Catherine
Published: (2009)

Multisite phosphorylation in T cell receptor proximal signalling
by: Mukhopadhyay, Himadri
Published: (2015)

Development of inducible transgenic mouse models for melanoma
by: Yao, Denggao
Published: (2009)

Behavioural characterisation of a transgenic mouse model of Huntington's disease
by: Carter, R. J.
Published: (2000)

A transgenic mouse model of hereditary motor and sensory neuropathy
by: Dati, Gabriele
Published: (2009)

In vivo investigation of NMDA receptors in schizophrenia with [123]-CNS1261 and single photon emission tomography
by: Bressan, Rodrigo Alfonseca
Published: (2003)

The role of β4-containing nicotinic acetylcholine receptors in nicotine addiction
by: Harrington, Lauriane
Published: (2015)

Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease
by: Jacqueline Shehadeh, et al.
Published: (2006-02-01)

Activation of ERK and Akt Signaling in Focal Cerebral Ischemia: Modulation by TGF-α and Involvement of NMDA Receptor
by: Bibiana Friguls, et al.
Published: (2002-12-01)

Analysis of genotype and phenotype of LRC receptor transgenic mice
by: Belkin, Danny
Published: (2003)

Transgenic approaches to investigate CIZ1 behaviour and function in the mouse heart
by: Bageghni, Sumia Abdulaziz
Published: (2012)

Place cell physiology in a transgenic mouse model of Alzheimer's disease
by: Yi, M.
Published: (2009)

The short and long term effects of neonatal NMDA receptor antagonist treatment : a model for schizophrenia?
by: Harris, L. J. W.
Published: (2003)

The neuronal nicotinic acetylcholine receptor as a potential symptomatic and neuroprotective target in Parkinson's disease
by: Visanji, Naomi
Published: (2004)

Neuronal nicotinic acetylcholine receptors in the human thalamus and related brain areas in health and disease
by: Ray, Melissa
Published: (2005)

α7 nicotinic acetylcholine receptors : regulation of plasticity and network activity in the prelimbic cortex
by: Udakis, Matthew
Published: (2016)

A Role for the NMDA receptor in synaptic plasticity in the hippocampus of the Fmr1 transgenic mouse model of Fragile X Syndrome
by: Bostrom, Crystal A.
Published: (2012)

P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease
by: Jing Fan, et al.
Published: (2012-03-01)

Conditional knockout of NMDA receptors in dopamine neurons prevents nicotine-conditioned place preference.
by: Lei Phillip Wang, et al.
Published: (2010-01-01)

A transgenic mouse model assessing the role of lung specific IFN in mycobacterial infections
by: Reuter, Christine Hedwig
Published: (2003)

Investigation of pre-erythrocytic malaria vaccines in a mouse model using transgenic parasites
by: Watkins, Katherine Ruth
Published: (2005)